It’s time for a greater role for pharmacists in asthma management
I’ve returned from a Saturday morning in community pharmacy practice and am reflecting on the number of patients I saw with asthma. I checked...
Beyond politics; patient groups and the art of influence
“What is a patient group?”, a friend of mine enquired during one of our recent regular political discussions. It struck me afterwards that given...
The real cost of over the counter prescriptions
NHS England recently published its guidance for CCGs on the over the counter (OTC) items which should not be routinely prescribed in primary care...
David wants understanding between NHS & industry
Not who you say I am:
Pharma companies need to be clear who they’re talking to and why they’re talking to them. Last week a pharma...
Two takes: Bad habits – help or hindrance?
In this month’s emotive opinion battle, we ask two healthcare professionals if we should be encouraging patients to evaluate their lifestyle choices, or are...
Pharmacists are the last step between HCPs and patients
Having the right medicine at the right time and administered in the right way can be the difference between that patient continuing their treatment...
AI is launching healthcare into the future
With tales of Victorian era conditions on hospital wards, chronic ambulance queues and surgery delays reminiscent of the NHS’s nadir in the early 1990s,...
Does a pharmacy career appeal to young people?
For pharmacy graduates forcing doors open is essential. Over 30 years ago I made the decision to study pharmacy at Nottingham University, with little understanding...
Tracking progress of the Rare Disease Strategy
February’s magazine focused on rare diseases, but how can implementation plans for the Rare Disease Strategy be properly monitored? The Rare Disease Strategy implementation plans...
Outcome-based contracts for medicines: What’s the deal?
Outcome-based contracts for medicines – is there enough financial headroom to attract pharma? In the January and February issues of Pf Magazine we discussed the...
Latest articles
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners on the positive patient outcomes that come from working together
The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Popular articles
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics and precision medicine
How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Addressing the skills shortage in life sciences
How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...